UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
46 hedge funds and large institutions have $5.24M invested in Unity Biotechnology in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
97% less capital invested
Capital invested by funds: $153M → $5.24M (-$148M)
Holders
46
Holding in Top 10
3
Calls
$2.28M
Puts
$49K
Top Buyers
| 1 | +$347K | |
| 2 | +$131K | |
| 3 | +$61.1K | |
| 4 |
BlackRock
New York
|
+$60.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$52K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$774K | |
| 3 | -$721K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$685K |
| 5 |
6CM
683 Capital Management
New York
|
-$658K |